The clinical significance of neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio in Guillain–Barré syndrome
- 3 January 2018
- journal article
- research article
- Published by Taylor & Francis Ltd in International Journal of Neuroscience
- Vol. 128 (8), 729-735
- https://doi.org/10.1080/00207454.2017.1418342
Abstract
Purpose/Aim of the study: Guillain Barré syndrome (GBS) is a severe peripheral nervous disease that leads to muscle weakness and areflexia. We now commonly accept a synthesis that inflammation and immunity play key role in GBS pathogenesis. Many studies pointed out that neutrophil-to-lymphocyte ratio (NLR) and monocyte-to-lymphocyte ratio (MLR) are novel promising markers of inflammation or immunity. Our study aimed to evaluate whether the NLR and the MLR were associated to GBS or not. Materials and Methods: We measured blood cell count in 334 individuals including 117 GBS and 217 healthy controls. Results: Our findings demonstrated that the GBS patients had higher levels of NLR and MLR than the healthy controls. The severe group also had higher levels of NLR and MLR compared to the mild group. We took the method of receiver-operating characteristic curve to find out the cut-off value of NLR for GBS occurrence and severity; it was 2.295 and 3.05, respectively. The cut-off values of MLR for GBS incidence and severity were the same, it was 0.235. Conclusion: In the setting of GBS, the NLR and MLR were significantly increased and they may be pathophysiologically and clinically relevant in GBS. The NLR and MLR would be new biomarkers of medical application.Funding Information
- Natural Science Foundation of Zhejiang Province (LQ15H090008)
This publication has 30 references indexed in Scilit:
- The Evaluation of Neutrophil-Lymphocyte Ratio in Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 2012
- Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian populationInternational Archives of Medicine, 2012
- A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome StudyEuropean Journal of Cancer, 2011
- Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-AnalysisNeuroepidemiology, 2011
- Distribution of Inducible Nitric Oxide Synthase and Tumor Necrosis Factor-α in the Peripheral Nervous System of Lewis Rats during Ascending Paresis and Spontaneous Recovery from Experimental Autoimmune NeuritisNeuroimmunomodulation, 2009
- Improved outcome of EAN, an animal model of GBS, through amelioration of peripheral and central inflammation by minocyclineJournal of Cellular and Molecular Medicine, 2009
- Infections and vaccinations preceding childhood Guillain-Barré syndrome: a prospective studyEuropean Journal of Pediatrics, 2006
- Modulating CCR2 and CCL2 at the blood–brain barrier: relevance for multiple sclerosis pathogenesisBrain, 2005
- Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain–Barré syndromeJournal of Neuroimmunology, 1998
- Inflammatory mediators in demyelinating disorders of the CNS and PNSJournal of Neuroimmunology, 1992